Merkliste

    Masterka® is FCI latest innovation for treatment of congenital nasolacrimal duct obstruction resistant to probing.

    Weitere Produktinformationen

    Masterka®

    FCI EXCLUSIVE

    Masterka® is FCI latest innovation for treatment of congenital nasolacrimal duct obstruction resistant to probing.

    Unlike the traditional “pulled” technique in which the stent is advanced through the nasolacrimal system and retrieved through the nose by pulling on the guide probe or thread, the Masterka® has no metallic probe or suture attached to it and, therefore, it is not pulled out of the nose.

    Instead, the Masterka® is pushed into the nasolacrimal duct and anchored in place at the punctum by a plug-like fixation head.

    Main characteristics:

    • Easy to insert
    • No nasal retrieval, no knot or sutures needed
    • Less traumatic
    • Available in 3 lenghts
    • 3 mm plug collarette
    • Requires sizer (S1.1289) to select the length & 0.3 mm disposable punctum dilator and plug inserter (S1.3090)
    • Sterile, Single use

    Masterka® is a Class IIb medical devices manufactured by FCI S.A.S. - Notified Body: GMED CE n°0459.


    Erhältlich bei:


    Produkt direkt anfragen: